Guangzhou Anjie Biomedical Technology Co., Ltd. Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2018
NCT03706326
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Anji Pharma | Guangzhou Anjie Biomedical Technology Co., Ltd.

Active Ingredients

Drugs in Phase 3 Trials (1)

metformin (glucophage) (2 trials)

Drugs in Phase 2 Trials (3)

muc1 car-t cells (2 trials)

pd-1 knockout t cells (1 trial)

pradigastat (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constipation (Phase 2)

Esophageal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 4